PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
BBP vs. TXG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

BBP vs. TXG

Last updated Jun 5, 2026

BBP (Virtus LifeSci Biotech Products ETF) is Health & Biotech Equities fund tracking the LifeSci Biotechnology Products Index, while TXG (10x Genomics, Inc.) is a stock. Over the past 5 years, BBP returned 10.90%/yr vs -28.57%/yr for TXG. At a 0.48 correlation, their price movements are largely independent.

Performance

BBP vs. TXG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and 10x Genomics, Inc. (TXG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBP achieves a 8.38% return, which is significantly lower than TXG's 105.40% return.

BBP

1D
2.44%
1M
-0.92%
YTD
8.38%
6M
9.14%
1Y
48.00%
3Y*
17.11%
5Y*
10.90%
10Y*
11.72%

TXG

1D
4.17%
1M
52.20%
YTD
105.40%
6M
84.57%
1Y
258.67%
3Y*
-15.22%
5Y*
-28.57%
10Y*
—
*Multi-year figures are annualized to reflect compound growth (CAGR)

BBP vs. TXG - Yearly Performance Comparison

2026 (YTD)2025202420232022202120202019
BBP
Virtus LifeSci Biotech Products ETF		8.38%33.15%3.32%17.88%0.85%-8.17%22.24%14.29%
TXG
10x Genomics, Inc.		105.40%13.58%-74.34%53.57%-75.54%5.20%85.70%44.55%

Correlation

The correlation between BBP and TXG is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.37

Correlation (3Y)
Calculated over the trailing 3-year period

0.45

Correlation (5Y)
Calculated over the trailing 5-year period

0.52

Correlation (All Time)
Calculated using the full available price history since Sep 13, 2019

0.48

The correlation between BBP and TXG shifts across timeframes, from 0.37 (1 year) to 0.52 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Virtus LifeSci Biotech Products ETF

10x Genomics, Inc.

Often compared with BBP:
BBP vs. BBCBBP vs. SBIOBBP vs. BTECBBP vs. FBTBBP vs. IBBQBBP vs. IHEBBP vs. WDNA
Often compared with TXG:
TXG vs. XDWT.DETXG vs. SBRATXG vs. METATXG vs. DHRTXG vs. SPYTXG vs. AAPLTXG vs. CRSP

Return for Risk

BBP vs. TXG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
BBP
BBP Risk / Return Rank: 7070
Overall Rank
BBP Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
BBP Sortino Ratio Rank: 6262
Sortino Ratio Rank
BBP Omega Ratio Rank: 5555
Omega Ratio Rank
BBP Calmar Ratio Rank: 8989
Calmar Ratio Rank
BBP Martin Ratio Rank: 8282
Martin Ratio Rank
TXG
TXG Risk / Return Rank: 9595
Overall Rank
TXG Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
TXG Sortino Ratio Rank: 9494
Sortino Ratio Rank
TXG Omega Ratio Rank: 9191
Omega Ratio Rank
TXG Calmar Ratio Rank: 9797
Calmar Ratio Rank
TXG Martin Ratio Rank: 9696
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBP vs. TXG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and 10x Genomics, Inc. (TXG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

BBPTXGDifference
Sharpe ratioReturn per unit of total volatility
2.02
3.89

-1.87

Sortino ratioReturn per unit of downside risk
2.87
3.95

-1.08

Omega ratioGain probability vs. loss probability

1.33

1.45

-0.12

Calmar ratioReturn relative to maximum drawdown

5.20

9.36

-4.16

Martin ratioReturn relative to average drawdown

16.27

21.65

-5.38

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBP vs. TXG - Sharpe Ratio Comparison

The current BBP Sharpe Ratio is 2.02, which is lower than the TXG Sharpe Ratio of 3.89. The chart below compares the historical Sharpe Ratios of BBP and TXG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

BBPTXGDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.02

3.89

-1.87

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.42

-0.42

+0.84

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.43

—

—

Sharpe Ratio (All Time)

Calculated using the full available price history

0.40

-0.10

+0.50

Drawdowns

BBP vs. TXG - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum TXG drawdown of -96.47%. Use the drawdown chart below to compare losses from any high point for BBP and TXG.

Loading charts...

Drawdown Indicators

BBPTXGDifference

Max Drawdown

Largest peak-to-trough decline

-44.32%

-96.47%

+52.15%

Max Drawdown (1Y)

Largest decline over 1 year

-9.28%

-28.03%

+18.75%

Max Drawdown (3Y)

Largest decline over 3 years

-26.09%

-88.66%

+62.57%

Max Drawdown (5Y)

Largest decline over 5 years

-38.28%

-96.45%

+58.17%

Max Drawdown (10Y)

Largest decline over 10 years

-44.32%

—

—

Current Drawdown

Current decline from peak

-4.18%

-83.45%

+79.27%

Average Drawdown

Average peak-to-trough decline

-12.02%

-59.63%

+47.61%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.96%

12.07%

-9.11%

Volatility

BBP vs. TXG - Volatility Comparison

The current volatility for Virtus LifeSci Biotech Products ETF (BBP) is 8.03%, while 10x Genomics, Inc. (TXG) has a volatility of 16.61%. This indicates that BBP experiences smaller price fluctuations and is considered to be less risky than TXG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

BBPTXGDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.03%

16.61%

-8.58%

Volatility (6M)

Calculated over the trailing 6-month period

18.52%

45.57%

-27.05%

Volatility (1Y)

Calculated over the trailing 1-year period

23.84%

67.42%

-43.58%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

26.37%

68.25%

-41.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.41%

66.73%

-39.32%

Dividends

BBP vs. TXG - Dividend Comparison

Neither BBP nor TXG has paid dividends to shareholders.

PositionTTM20252024202320222021202020192018201720162015
BBP
Virtus LifeSci Biotech Products ETF		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.18%0.00%1.29%
TXG
10x Genomics, Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

BBP and TXG have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TXG has higher volatility (16.61%) compared to BBP (8.03%). In terms of maximum drawdown, BBP dropped -44.32% vs TXG's -96.47%.

TXG currently has the higher Sharpe Ratio (3.89 vs 2.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBP and TXG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer